<DOC>
	<DOCNO>NCT00895323</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , radionuclide image use bispecific antibody , may help find colorectal cancer cell learn extent disease . PURPOSE : This phase I trial study well bispecific antibody work find tumor cell patient colorectal cancer .</brief_summary>
	<brief_title>Bispecific Antibody Finding Tumor Cells Patients With Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Assess pharmacokinetics tissue distribution anti-CEA x anti-HSG bispecific monoclonal antibody TF2 patient colorectal cancer . OUTLINE : This multicenter study . Patients receive iodine I 131-labeled anti-CEA x anti-HSG bispecific monoclonal antibody TF2 ( ^131I-TF2 ) IV 10-20 minute day 1 . Patients also undergo whole-body external scintigraphy various time study . Blood sample collect baseline periodically ^131I-TF2 infusion pharmacokinetic study ^131I-TF2 biodistribution ELISA radioactivity measurement .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Antibodies , Bispecific</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colorectal cancer Radiological documentation disease prefer , require PATIENT CHARACTERISTICS : Karnofsky performance status 70100 % Life expectancy ≥ 3 month WBC ≥ 3,000/mm³ Neutrophil count ≥ 1,500/mm³ Platelet count ≥ 100,000/mm³ Serum creatinine normal Bilirubin ≤ 1.5 time upper limit normal ( ULN ) AST/ALT &lt; 2 time ULN Not pregnant nursing Fertile patient must use effective contraception 1 month completion study therapy No medical condition might prevent full participation protocolrequired test followup No institutionalized patient ( e.g. , prison mental health institution ) PRIOR CONCURRENT THERAPY : No concurrent chemotherapy treatment would compromise safety efficacy protocol assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>